{"contentid": 488388, "importid": NaN, "name": "Deal for further 100 million doses of Pfizer and BioNTech jab to go to EU", "introduction": "Pfizer and BioNTech are to supply an additional 100 million doses of Comirnaty, the companies\u00e2\u0080\u0099 COVID-19 vaccine, to the 27 European Union (EU) member states in 2021.", "content": "<p>Pfizer (NYSE: PFE) and BioNTech (Nasdaq: BNTX) are to supply an additional 100 million doses of Comirnaty, the companies&rsquo; COVID-19 vaccine, to the 27 European Union (EU) member states in 2021.</p>\n<p>The announcement is a result of the European Commission&rsquo;s (EC) decision to exercise its option to buy an additional 100 million doses under its expanded Advanced Purchase Agreement signed in February. This brings the total number of doses to be delivered to the EU to 600 million.</p>\n<p><span class=\"pullQuote\">\"The largest cumulative supply agreement for Comirnaty that we have agreed to date globally\"</span>Although there have been serious but treatable allergic reactions in a very small number of people given the Pfizer-BioNTech vaccine, more serious concerns over blood clots have impacted the rollout of the jabs from AstraZeneca (LSE: AZN) and Johnson &amp; Johnson (NYSE: JNJ).</p>\n<p>There have also been supply issues with the AstraZeneca vaccine in Europe, causing a degree of conflict between the company and the EU and some of its member states.</p>\n<p>No such tensions exist where the Pfizer and BioNTech vaccine is concerned.</p>\n<p>Albert Bourla, chairman and chief executive of Pfizer, said: &ldquo;We remain committed to moving as quickly and safely as possible to bring this vaccine to more people in Europe, as the deadly virus continues to wreak havoc across the continent.</p>\n<p>&ldquo;To date, we have met all of our supply commitments to the European Commission and we plan to deliver 250 million doses to the EU in Q2, a four-fold increase on Q1&rsquo;s agreed quantity.&rdquo;</p>\n<p>Sean Marett, chief business and chief commercial officer of BioNTech, added: &ldquo;The additional 100 million doses from this option exercise will further help to support the acceleration of the vaccination campaigns throughout the EU.</p>\n<p>&ldquo;We now intend to deliver a total of 600 million doses to the EU this year, which covers two thirds of the EU population and represents the largest cumulative supply agreement for Comirnaty that we have agreed to date globally.&rdquo;</p>\n<p>&nbsp;</p>", "date": "2021-04-19 13:37:00", "meta_title": NaN, "meta_keywords": "million, doses, Pfizer, BioNTech, supply, vaccine, Comirnaty, European, additional, member, states, agreement, Deal, Union, COVID-, agreed, date, companies", "meta_description": "Pfizer and BioNTech are to supply an additional 100 million doses of Comirnaty, the companies\u00e2\u0080\u0099 COVID-19 vaccine, to the 27 European Union (EU) member states in ", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-19 13:33:59", "updated": "2021-04-19 14:13:25", "access": NaN, "url": "https://www.thepharmaletter.com/article/deal-for-further-100-million-doses-of-pfizer-and-biontech-jab-to-go-to-eu", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "biontech_vaccine_large.jpg", "image2id": "biontech_vaccine_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Infectious diseases, Vaccines", "topic_tag": "Coronavirus, Focus On, Government Affairs", "geography_tag": "Germany, USA", "company_tag": "BioNTech, Pfizer", "drug_tag": "Comirnaty", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-19 13:37:00"}